Randall B. Brenner

Companies

• Paratek Pharmaceuticals, Inc.Chief Development & Regulatory Sep 27, 2019 to Sep 21, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PPParatek Pharmaceuticals, Inc.0 shares²Sep 21, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2023Returned to company 85,500 shares of Paratek Pharmaceuticals, Inc.²
• Sep 21, 2023Returned to company 329,709 shares of Paratek Pharmaceuticals, Inc.²
• Aug 9, 2023Sold 27,603 shares at $2.20 of Paratek Pharmaceuticals, Inc.³
• Aug 8, 2023Granted 67,500 shares of Paratek Pharmaceuticals, Inc.³
• Dec 21, 2022Sold 4,539 shares at $1.99 of Paratek Pharmaceuticals, Inc.⁴
• Dec 20, 2022Granted 15,000 shares of Paratek Pharmaceuticals, Inc.⁴
• Dec 13, 2022Sold 18,177 shares at $1.96 of Paratek Pharmaceuticals, Inc.⁵
• Dec 12, 2022Sold 11,105 shares at $1.98 of Paratek Pharmaceuticals, Inc.⁵
• Oct 28, 2022Sold 3,516 shares at $3.47 of Paratek Pharmaceuticals, Inc.⁶
• Oct 25, 2022Granted 8,500 shares of Paratek Pharmaceuticals, Inc.⁷
• Aug 9, 2022Sold 19,608 shares at $2.66 of Paratek Pharmaceuticals, Inc.⁸
• Aug 8, 2022Granted 47,727 shares of Paratek Pharmaceuticals, Inc.⁸
• Mar 15, 2022Granted 67,500 shares of Paratek Pharmaceuticals, Inc.⁹
• Dec 15, 2021Sold 15,780 shares at $4.27 of Paratek Pharmaceuticals, Inc.¹⁰
• Dec 14, 2021Sold 7,635 shares at $4.37 of Paratek Pharmaceuticals, Inc.¹⁰
• Dec 13, 2021Sold 4,479 shares at $4.42 of Paratek Pharmaceuticals, Inc.¹⁰